Melanoma: BRAFi Rechallenge

Melanoma: BRAFi Rechallenge

Melanoma is the most aggressive type of skin cancer. Half of melanoma cases are characterized by the mutation BRAF V600. The case presented concerns a 41-year-old patient with locally advanced melanoma, being positive in mutation BRAF V600. The patient underwent surgery and received additional targe...

Full description

Bibliographic Details
Main Authors: Christoforos S. Kosmidis, Konstantina Papadopoulou, Chrysi Maria Mystakidou, Evanthia Papadopoulou, Stylianos Mantalovas, Nikolaos Varsamis, Charilaos Koulouris, Vasiliki Theodorou, Konstantinos Papadopoulos, Christina Sevva, Petrina Miltiadous, Savvas Petanidis, Eleni Georgakoudi, Eleni Papadopoulou, Sofia Baka
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Medicina
Subjects:
targeted therapy
BRAFi rechallenge
metastatic melanoma
BRAF V600 mutation
BRAF inhibitor
Online Access:https://www.mdpi.com/1648-9144/59/5/975

Internet

https://www.mdpi.com/1648-9144/59/5/975

Similar Items